Records containing: Leukemia, Myeloid, Chronic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-11-05A Phase Ib Study of the Pharmacokinetics, Safety and Efficacy of Orally Administered HQP1351 in Subjects With Refractory Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (Ph+ ALL)
-
CLINICAL_TRIALS study record update · 2023-03-01The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
-
CLINICAL_TRIALS study record update · 2021-07-14A Phase II, Multicentre Study of Oral LBH589 in Patients With Accelerated Phase or Blast Phase (Blast Crisis) Chronic Myeloid Leukemia With Resistant Disease Following Treatment With at Least Two BCR-ABL Tyrosine Kinase Inhibitors
-
CLINICAL_TRIALS study record update · 2021-01-22Allogeneic Transplant for Hematological Malignancy
-
CLINICAL_TRIALS study record update · 2019-05-01Randomized Trial of Unmanipulated Versus Expanded Cord Blood
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-04-03Transplantation of Expanded and Unexpanded Umbilical Cord Blood Units Following Myeloablative Chemotherapy for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2017-11-29Treatment of Relapsed Leukemia After Allogeneic Bone Marrow Transplantation Using Donor-derived Lymphocytes
-
CLINICAL_TRIALS study record update · 2017-07-11Use of Cyclophosphamide/Fludarabine to Promote in Vivo Expansion of Donor Lymphocyte Infusions (DLI) to Enhance Efficacy After Allogeneic Transplant
-
CLINICAL_TRIALS study record update · 2017-03-30Phase 1b Open-Label, Multicenter Clinical Study of the Safety and Activity of Intravenous Administration of SNS-595 in Patients With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2017-03-06Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy
-
CLINICAL_TRIALS study record update · 2016-05-11Randomized Trial of Therapy of Early Phase Chronic Myelogenous Leukemia With High-Dose Imatinib Mesylate (Gleevec) Alone or in Combination With Peg-Alpha Interferon (PEG-Intron) and Sargramostim (GM-CSF)
-
CLINICAL_TRIALS study record update · 2016-03-07A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
-
CLINICAL_TRIALS study record update · 2016-02-17Phase Ib Study Evaluating the Safety and Exploring the Molecular and Cytogenetic Response of Combination Therapy With Dasatinib and Ipilimumab in Patients With Chronic or Accelerated Phase Chronic Myeloid Leukemia
-
CLINICAL_TRIALS study record update · 2015-12-16An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
-
CLINICAL_TRIALS study record update · 2015-09-25Phase II Study: HSCT Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
-
CLINICAL_TRIALS study record update · 2015-06-17Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia
-
CLINICAL_TRIALS study record update · 2012-12-17Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide
-
CLINICAL_TRIALS study record update · 2012-12-07A Phase II Study of Parathyroid Hormone Following Myeloablative Sequential Unrelated Cord Blood Transplantation
-
CLINICAL_TRIALS study record update · 2012-09-07Phase II Exploratory Study Of AG-858 Plus Gleevec™ In Patients With Chronic Myelogenous Leukemia (CML) In Chronic Phase Who Are Cytogenetically Positive After Treatment With Gleevec™
-
CLINICAL_TRIALS study record update · 2012-08-01Phase I Study of Zarnestra (R115777.USA30) and Gleevec (Imatinib Mesylate) in Chronic Phase Chronic Myelogenous Leukemia (CML)
-
CLINICAL_TRIALS study record update · 2012-06-04Evaluation of Benefit and Side Effects of Double Umbilical Cord Blood Units Stem Cell Transplantation in Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2012-06-04Safety Assessment of a Peptide Vaccine Derived From Bcr-abl Along With Cytokine Genes in CML Patients Undergoing Imatinib Treatment
-
CLINICAL_TRIALS study record update · 2011-12-13ClinicalTrials.gov study NCT00538447
-
CLINICAL_TRIALS study record update · 2011-10-05Study to Evaluate Efficacy and Safety of Glivec® in Combination With Vincristine and Dexamethasone in Patients With Lymphoid Blast Crisis CML or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Relapse or Refractory
-
CLINICAL_TRIALS study record update · 2011-07-07An Open-label, Randomized Study of Dasatinib vs High-dose (800-mg) Imatinib in the Treatment of Subjects With Chronic Phase Chronic Myeloid Leukemia Who Have Had a Suboptimal Response After at Least 3 Months of Therapy With 400 mg Imatinib